DNA methylation profiling: an emerging paradigm for cancer diagnosis

A Papanicolau-Sengos, K Aldape - Annual Review of Pathology …, 2022 - annualreviews.org
Histomorphology has been a mainstay of cancer diagnosis in anatomic pathology for many
years. DNA methylation profiling is an additional emerging tool that will serve as an adjunct …

The 2016 World Health Organization classification of tumors of the central nervous system: a summary

DN Louis, A Perry, G Reifenberger, A Von Deimling… - Acta …, 2016 - Springer
Abstract The 2016 World Health Organization Classification of Tumors of the Central
Nervous System is both a conceptual and practical advance over its 2007 predecessor. For …

The whole-genome landscape of medulloblastoma subtypes

PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt… - Nature, 2017 - nature.com
Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose
debilitating effects on the develo** child, and highlight the need for molecularly targeted …

Intertumoral heterogeneity within medulloblastoma subgroups

FMG Cavalli, M Remke, L Rampasek, J Peacock… - Cancer cell, 2017 - cell.com
While molecular subgrou** has revolutionized medulloblastoma classification, the extent
of heterogeneity within subgroups is unknown. Similarity network fusion (SNF) applied to …

Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience

D Capper, D Stichel, F Sahm, DTW Jones… - Acta …, 2018 - Springer
Recently, we described a machine learning approach for classification of central nervous
system tumors based on the analysis of genome-wide DNA methylation patterns [6]. Here …

Resolving medulloblastoma cellular architecture by single-cell genomics

V Hovestadt, KS Smith, L Bihannic, MG Filbin… - Nature, 2019 - nature.com
Medulloblastoma is a malignant childhood cerebellar tumour type that comprises distinct
molecular subgroups. Whereas genomic characteristics of these subgroups are well …

Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03)

A Gajjar, GW Robinson, KS Smith, T Lin… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE SJMB03 (ClinicalTrials. gov identifier: NCT00085202) was a phase III risk-
adapted trial that aimed to determine the frequency and clinical significance of biological …

Medulloblastoma

PA Northcott, GW Robinson, CP Kratz… - Nature reviews Disease …, 2019 - nature.com
Medulloblastoma (MB) comprises a biologically heterogeneous group of embryonal tumours
of the cerebellum. Four subgroups of MB have been described (WNT, sonic hedgehog …

Childhood cerebellar tumours mirror conserved fetal transcriptional programs

MC Vladoiu, I El-Hamamy, LK Donovan, H Farooq… - Nature, 2019 - nature.com
Study of the origin and development of cerebellar tumours has been hampered by the
complexity and heterogeneity of cerebellar cells that change over the course of …

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

EC Schwalbe, JC Lindsey, S Nakjang, S Crosier… - The Lancet …, 2017 - thelancet.com
Background International consensus recognises four medulloblastoma molecular
subgroups: WNT (MB WNT), SHH (MB SHH), group 3 (MB Grp3), and group 4 (MB Grp4) …